Related Experiment Video
Updated: Aug 18, 2025
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.0K
Erythrodermic psoriasis improved by Tildrakizumab
Giampaolo Trevisan1, Lerica Germi1, Luigi Naldi1
1Department of Dermatology, San Bortolo Hospital, Vicenza, Italy.
Dermatology Reports
|December 9, 2022
Summary
Erythrodermic psoriasis (EP) is severe. Tildrakizumab, an interleukin-23 inhibitor, successfully treated a case of EP in an obese patient, demonstrating its safety and efficacy.
Area of Science:
- Dermatology
- Immunology
Background:
- Erythrodermic psoriasis (EP) is a severe, rare psoriasis variant.
- Treatment often requires hospitalization and immunosuppressants.
Purpose of the Study:
- To report the successful treatment of erythrodermic psoriasis with Tildrakizumab.
Main Methods:
- A case study of an obese male patient with erythrodermic psoriasis.
- Treatment administered with Tildrakizumab, an interleukin-23 inhibitor.
Main Results:
- The patient achieved successful and safe treatment outcomes.
- Tildrakizumab demonstrated efficacy in managing severe erythrodermic psoriasis.
Conclusions:
- Tildrakizumab is a viable therapeutic option for erythrodermic psoriasis.
- This case highlights the potential of IL-23 inhibitors in managing severe skin conditions.
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
210
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
210
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
244
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
244
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
188
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
188
01:24T Cell Types and Functions
1.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.2K
01:21Rheumatic Heart Disease III: Medical Management
26
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
26
01:29Drugs for Treatment of Ulcerative Colitis in IBD
219
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
219